| Betterchem |

|
|
| FDA approval activities
for this prescription drug:
Orfadin (Nitisinone) Capsules, Swedish Orphan, (R&R Registration is the U.S. Agent NDA 21-232 1/18/02 2/5/02 2/5/02 2/28/02 Orfadin Indications: An adjunct to dietary restriction of tyrosine and phenylalanine in the treatment of hereditary tyrosinemia tyep 1. |
|
© 2009 Betterchem.com
|